VMD

Viemed Healthcare, Inc. [VMD] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

VMD Stock Summary

Top 10 Correlated ETFs

VMD


Top 10 Correlated Stocks

VMD


In the News

04:30 28 Mar 2024 VMD

Viemed Healthcare Announces Date and Time for Conference Call

LAFAYETTE, La., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it will host its Year End Conference Call on Thursday, March 7, 2024 at 11:00 a.m. ET.

09:00 28 Mar 2024 VMD

Viemed Healthcare to Present at Stifel 2023 Healthcare Conference

LAFAYETTE, La., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD and TSX:VMD.TO), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it will participate in the Stifel 2023 Healthcare Conference on November 15, 2023, in New York, New York at the Lotte New York Palace Hotel, located at 455 Madison Ave.

01:19 28 Mar 2024 VMD

Viemed Healthcare, Inc. (VMD) Q3 2023 Earnings Call Transcript

Viemed Healthcare, Inc. (NASDAQ:VMD ) Q3 2023 Earnings Conference Call November 2, 2023 11:00 AM ET Company Participants Todd Zehnder - COO Casey Hoyt - CEO Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Doug Cooper - Beacon Securities Limited Michael Freeman - Raymond James Operator Greetings, and welcome to Viemed's 3Q 2023 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded.

09:00 28 Mar 2024 VMD

Viemed Healthcare to Participate in Upcoming Investor Conferences

LAFAYETTE, La., Aug. 31, 2023 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD and TSX:VMD.TO), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it will participate in the following upcoming investor conferences:

07:01 28 Mar 2024 VMD

3 Undervalued Small-Cap Stocks for Your Labor Day Watchlist

One reason August can be volatile is that trading volume is down. Although news items may stir up activity, there's a difference between activity and productive action that really moves markets.

04:29 28 Mar 2024 VMD

The 7 Most Undervalued Stocks Under $10 to Buy Now: August 2023

If you're hurting from inflation – and there's a good chance you are – these stocks to buy under $10 might offer what you're looking for. To start, these “cheap” investment ideas offer perceived affordability, which goes a long way.

03:36 28 Mar 2024 VMD

Viemed Healthcare: Qualified Growth Company, HMP Transaction Accretive To Value

Viemed Healthcare's equity stock has consolidated by ~20% after a strong rally, but the company's economic outlook remains unchanged. The acquisition of HMP has added potential value to VMD, expanding its geographical reach and bringing revenue synergies. Viemed Healthcare's Q2 earnings showed strong growth, with sales up 31% YoY, and the company expects continued expansion in FY'23 and FY'24.

09:00 28 Mar 2024 VMD

Viemed Healthcare Announces Date and Time for Conference Call

LAFAYETTE, La., July 25, 2023 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD and TSX:VMD.TO), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it will host its Quarterly Conference Call on Thursday, August 10, 2023 at 11:00 a.m. ET.

02:18 28 Mar 2024 VMD

Viemed Healthcare: Superb Growth Expectations, Reiterate Buy

Viemed Healthcare collected another quarter of sequential and YoY sales growth. Investors have revised expectations for the company and added $273mm in market cap off March 2022 lows.

08:31 28 Mar 2024 VMD

Viemed Healthcare, Inc. (VMD) Misses Q1 Earnings Estimates

Viemed Healthcare, Inc. (VMD) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.07 per share. This compares to earnings of $0.04 per share a year ago.

VMD Financial details

Company Rating
Strong Buy
Market Cap
352.17M
Income
10.24M
Revenue
184.41M
Book val./share
2.94
Cash/share
0.33
Dividend
-
Dividend %
-
Employees
996
Optionable
No
Shortable
Yes
Earnings
06 May 2024
P/E
31.86
Forward P/E
19.54
PEG
4.52
P/S
1.73
P/B
2.7
P/C
28.42
P/FCF
18.49
Quick Ratio
0.82
Current Ratio
1.14
Debt / Equity
0.07
LT Debt / Equity
0.05
-
-
EPS (TTM)
0.27
EPS next Y
0.48
EPS next Q
0.07
EPS this Y
68.75%
EPS next Y
75.95%
EPS next 5Y
75.95%
EPS last 5Y
3.26%
Revenue last 5Y
18.35%
Revenue Q/Q
5.55%
EPS Q/Q
16%
-
-
-
-
SMA20
9.99%
SMA50
24.3%
SMA100
49.04%
Inst Own
43.52%
Inst Trans
0.68%
ROA
6%
ROE
9%
ROC
0.11%
Gross Margin
61%
Oper. Margin
7%
Profit Margin
5%
Payout
-
Shs Outstand
38.49M
Shs Float
33.61M
-
-
-
-
Target Price
-
52W Range
5.9-12.01
52W High
-21.83%
52W Low
+87.6%
RSI
55.43
Rel Volume
0.78
Avg Volume
170.82K
Volume
132.91K
Perf Week
-1.88%
Perf Month
11.93%
Perf Quarter
38.14%
Perf Half Y
34%
-
-
-
-
Beta
1.373
-
-
Volatility
0.17%, 0.48%
Prev Close
3.19%
Price
9.38
Change
2.63%

VMD Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric History 2019-12-312020-12-312021-12-312022-12-31 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
2.023.392.963.594.62
Net income per share
0.210.810.230.160.25
Operating cash flow per share
0.480.910.570.721.14
Free cash flow per share
0.140.570.070.130.48
Cash per share
0.340.80.720.390.32
Book value per share
1.12.112.42.512.81
Tangible book value per share
1.12.112.42.512.06
Share holders equity per share
1.12.112.42.512.81
Interest debt per share
0.50.30.170.020.21
Market cap
246.43M300.65M206.14M292.23M316.97M
Enterprise value
252.59M280.8M184.25M276.01M314.47M
P/E ratio
28.919.5422.5946.9730.95
Price to sales ratio
3.072.291.762.11.7
POCF ratio
12.918.569.1610.536.88
PFCF ratio
43.2213.6374.9360.2516.28
P/B Ratio
5.643.682.173.012.8
PTB ratio
5.643.682.173.012.8
EV to sales
3.152.141.571.991.69
Enterprise value over EBITDA
16.178.237.7511.238.26
EV to operating cash flow
13.2388.199.956.83
EV to free cash flow
44.312.7366.9856.9116.15
Earnings yield
0.030.10.040.020.03
Free cash flow yield
0.020.070.010.020.06
Debt to equity
0.450.140.070.010.07
Debt to assets
0.240.10.060.010.05
Net debt to EBITDA
0.39-0.58-0.92-0.66-0.07
Current ratio
1.072.052.662.111.19
Interest coverage
27.8652.6136.4241.8936.59
Income quality
2.241.112.464.464.41
Dividend Yield
00000
Payout ratio
0.0500.010.040.04
Sales general and administrative to revenue
0.560.440.510.530.5
Research and developement to revenue
0.010.010.020.020.02
Intangibles to total assets
00000.2
Capex to operating cash flow
-0.7-0.37-0.88-0.83-0.58
Capex to revenue
-0.17-0.1-0.17-0.16-0.14
Capex to depreciation
-2.09-1.36-1.75-1.47-1.19
Stock based compensation to revenue
0.050.040.040.040.03
Graham number
2.36.213.533.024
ROIC
0.120.330.080.060.09
Return on tangible assets
0.10.280.080.050.08
Graham Net
-0.410.270.440.21-0.3
Working capital
1.9M24.16M29.5M20.88M6.21M
Tangible asset value
43.7M81.69M94.82M97.09M82.98M
Net current asset value
-11.09M16.31M24.17M19.79M-2.62M
Invested capital
0.450.140.070.010.07
Average receivables
10.19M11.95M13.54M15.06M16.88M
Average payables
5.29M3.4M2.67M2.94M3.4M
Average inventory
2.12M1.84M2.38M3.02M4.09M
Days sales outstanding
52.4634.3945.8840.535.95
Days payables outstanding
70.7414.9427.0817.8620.81
Days of inventory on hand
20.4716.4720.5424.0923.04
Receivables turnover
6.9610.617.959.0110.15
Payables turnover
5.1624.4313.4820.4317.54
Inventory turnover
17.8322.1617.7715.1515.84
ROE
0.20.390.10.060.09
Capex per share
-0.34-0.34-0.5-0.59-0.66

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.991.041.121.291.35
Net income per share
0.060.040.060.080.09
Operating cash flow per share
0.20.280.20.360.37
Free cash flow per share
0.060.150.040.170.15
Cash per share
0.390.620.260.210.33
Book value per share
2.552.622.692.832.94
Tangible book value per share
2.552.621.912.042.16
Share holders equity per share
2.552.622.692.832.94
Interest debt per share
0.020.010.420.290.21
Market cap
287.4M368.59M379.8M258.69M302.17M
Enterprise value
271.18M345.61M385.91M259.51M299.67M
P/E ratio
29.4760.7440.7522.1621.73
Price to sales ratio
7.669.328.775.245.8
POCF ratio
37.435.1249.8218.7321.35
PFCF ratio
136.0863.39245.8240.3852.87
P/B Ratio
2.963.683.632.382.67
PTB ratio
2.963.683.632.382.67
EV to sales
7.238.748.915.255.75
Enterprise value over EBITDA
65.6451.9646.2724.1925.21
EV to operating cash flow
35.2932.9350.6218.7921.18
EV to free cash flow
128.459.43249.7840.552.43
Earnings yield
0.0100.010.010.01
Free cash flow yield
0.010.0200.020.02
Debt to equity
0.010.010.160.10.07
Debt to assets
0.0100.110.070.05
Net debt to EBITDA
-3.93-3.460.730.08-0.21
Current ratio
2.111.991.141.141.19
Interest coverage
110.44-39.47145.0517.7521.96
Income quality
3.156.923.274.733.96
Dividend Yield
00000
Payout ratio
0.0800.300.04
Sales general and administrative to revenue
0.490.530.510.510.49
Research and developement to revenue
0.020.020.020.010.01
Intangibles to total assets
000.20.20.2
Capex to operating cash flow
-0.73-0.45-0.8-0.54-0.6
Capex to revenue
-0.15-0.12-0.14-0.15-0.16
Capex to depreciation
-1.27-0.98-1.17-1.24-1.38
Stock based compensation to revenue
0.040.040.030.030.03
Graham number
1.921.531.912.22.45
ROIC
0.020.010.020.020.03
Return on tangible assets
0.020.010.020.020.03
Graham Net
0.220.34-0.46-0.44-0.31
Working capital
20.88M23.28M4.37M4.31M6.21M
Tangible asset value
97.09M100.04M74.06M78.42M82.98M
Net current asset value
19.79M22.11M-8.66M-4.73M-2.62M
Invested capital
0.010.010.160.10.07
Average receivables
15.24M15.86M17.62M18.42M18.14M
Average payables
4.53M3.46M6.58M9.09M6.72M
Average inventory
3.38M3.51M3.96M4.57M4.64M
Days sales outstanding
36.9637.1339.3232.6631.68
Days payables outstanding
16.3224.6646.5744.3519.11
Days of inventory on hand
22.0119.9523.4122.3121.15
Receivables turnover
2.432.422.292.762.84
Payables turnover
5.513.651.932.034.71
Inventory turnover
4.094.513.844.034.25
ROE
0.030.020.020.030.03
Capex per share
-0.15-0.12-0.16-0.19-0.22

VMD Frequently Asked Questions

What is Viemed Healthcare, Inc. stock symbol ?

Viemed Healthcare, Inc. is a US stock , located in Lafayette of La and trading under the symbol VMD

What is Viemed Healthcare, Inc. stock quote today ?

Viemed Healthcare, Inc. stock price is $9.38 today.

Is Viemed Healthcare, Inc. stock public?

Yes, Viemed Healthcare, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap